Aesthetic Medicine Market, By Procedure Type (Invasive Procedures, Non-invasive Procedures),Key Factors

Aesthetic medicine is a type of cosmetic procedure which is used in the treatment to improve scars, wrinkles, liver spots, cellulite, unwanted hair, excess fat and others that will help in augmenting the physical appearance of the patient using minimally invasive and non-invasive procedure.

View Detailed Report: https://www.databridgemarketresearch.com/reports/global-aesthetic-medicine-market

Data Bridge Market Research analyses that the aesthetic medicine market is expected to reach the value of USD 26.68 Billion by the year 2029, at a CAGR of 9.34% during the forecast period. "Medical Spas and Beauty Centres" is the dominating the end-user segment in the global aesthetic market owing to the increasing personal disposable income.

Aesthetic Medicine Market Dynamics

Opportunities

Furthermore, advancements in technology extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Additionally, a high emphasis on streamlining imaging workflows will further expand the aesthetic medicine market's growth rate in the future. 

Drivers

Rising awareness regarding aesthetic procedure in emerging economies

Need for better looking skin and facial features are very common thing thorough the world and people are getting aware and now travelling around all globe just for these procedures and is driving the market.

Key Players Analysis:

Some of the major players operating in the aesthetic medicine market are Cynosure, Inc., Johnson & Johnson Services, Inc., Galderma Laboratories, L.P., Alma Lasers, ALLERGAN, Solta Medical, Lumenis, CANDELA CORPORATION., Dentsply Sirona., Merz Pharma, Bausch Health Companies Inc., SKIN TECH PHARMA GROUP, Bioxis pharmaceuticals, Obagi Cosmeceuticals LLC, ZO Skin Health, Teoxane, LA ROCHE-POSAY, Alumier Labs, Medik8 and Abbott among others.

Scope:

Application

Surgical

Non-surgical

Based on application, aesthetic medicine market is segmented into surgical and non-surgical

Route of administration

Oral

Topical

Based on route of administration, aesthetic medicine market is segmented into oral and topical.

North America dominates the aesthetic medicine market due to the high prevalence of cosmetic procedure among growing population and availability of skilled professionals within the region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the availability of skilled professional and increasing disposable income of the people.

Explore More Reports:

https://dbmrmarketreports.blogspot.com/2024/05/herbal-medicinal-products-market-to.html

https://dbmrmarketreports.blogspot.com/2024/05/adhesives-sealants-market-to-witness.html

https://dbmrmarketreports.blogspot.com/2024/05/individual-quick-freezing-market_26.html

https://dbmrmarketreports.blogspot.com/2024/05/ready-mix-concrete-market-to-reach-usd.html

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact Us:
Data Bridge Market Research
Email: Corporatesales@databridgemarketresearch.com

This release was published on openPR.